Tag: vaccine
Shares of Pfizer Just Got a Substantial Boost
There goes Pfizer (PFE).
The stock is popping on news it’s buying ReViral – a privately held, clinical-stage biopharmaceutical company focused on discovering, developing, and...
This is Why Pfizer Just Popped, As We Expected
Pfizer is pushing to higher highs.
In fact, as we noted on November 2, “After finding support around $41, the vaccine stock bolted to nearly...
This is Why Shares of Pfizer Could Race Higher
Pfizer is pushing to higher highs.
After finding support around $41, the vaccine stock bolted to nearly $46, and could test $47, even $50, near-term. ...
Johnson & Johnson (JNJ) May Be Ready to Rebound
Keep an eye on Johnson & Johnson (JNJ).
After pulling back from a high of $173.65, it caught support at $161.99. From here, the stock...
The Top 3 Vaccine Trades that Should be in All Portfolios
Moderna (MRNA) has been incredibly explosive for us.
The first time we highlighted opportunity, the stock traded at $72 on Oct. 20. At the moment,...
COVID-19 Vaccine: The Top Two Stocks to Consider Immediately
The pandemic is only getting worse.
At the moment, there are nearly 40 million global cases, with 1.1 million deaths. In the U.S., the count...
The Top Two Vaccine Stocks to Avoid
There’s no such thing as a perfect trial.
Fortunately, there are safeguards in place to stop trials in the event of a mishap. We’ve seen...
This Pandemic Stock Has Just Begun to Push Higher
Keep an eye on Altimmmune Inc. (ALT).
The stock is pushing higher thanks to more positive data on its COVID candidate.
The company just published positive pre-clinical...
The Top 3 COVID-19 Treatment Stocks to Watch
With the coronavirus showing no signs of slowing, the world is in desperate need for a treatment -- and fast. Thankfully, we may be...
Popular Post
